Research Topics
| Ann PartridgeSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot programAnn H Partridge
Dana Farber Cancer Institute, Boston, Massachusetts, USA
Cancer 119:158-63. 2013..Data were used to create and share treatment plans/summaries (TPSs) at the point of care...
Model program to improve care for a unique cancer population: young women with breast cancerAnn H Partridge
Dana Farber Cancer Institute and Brigham and Women s Hospital Harvard Medical School, Boston, MA 02215, USA
J Oncol Pract 8:e105-10. 2012..We believe this work will not only improve care for young women with breast cancer, but also may serve as a paradigm to overcome barriers to delivering optimal care for unique groups of patients in other settings...- Fertility (male and female) and menopauseKathryn J Ruddy
Dana Farber Cancer Institute, Boston, MA 02215, USA
J Clin Oncol 30:3705-11. 2012..For cancer survivors who experience menopausal symptoms, lifestyle changes may be beneficial, and hormonal and nonhormonal pharmacologic agents are well proven to reduce symptom burden... - The effect of age on delay in diagnosis and stage of breast cancerAnn H Partridge
Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02115, USA
Oncologist 17:775-82. 2012..We sought to examine the relationship among young age (≤40 years), the likelihood of a delay in diagnosis, and stage... 
Fertility and adjuvant treatment in young women with breast cancerAnn H Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 44 Binney Street, D1210 Boston, MA 02115, USA
Breast 16:S175-81. 2007..Ongoing and future prospective studies evaluating fertility and pregnancy issues for young breast cancer survivors are warranted for this vulnerable population facing this difficult issue...- Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancerAnn H Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Clin Oncol 26:556-62. 2008..Previous research evaluating adherence to tamoxifen therapy among women with early-stage breast cancer has revealed adherence estimates ranging from 25% to 96%. No previous studies have focused on adherence to adjuvant aromatase inhibitors... - Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort studyAnn Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA
J Natl Cancer Inst 100:243-51. 2008..Preliminary studies have suggested that women with DCIS may overestimate their risk of disease recurrence. Few data exist regarding psychosocial outcomes for women with DCIS... - Fertility and menopausal outcomes in young breast cancer survivorsAnn H Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
Clin Breast Cancer 8:65-9. 2008..We evaluated these outcomes among young breast cancer survivors in collaboration with the Young Survival Coalition, an international advocacy group for young women with breast cancer... - The impact of sharing results of a randomized breast cancer clinical trial with study participantsAnn H Partridge
Dana Farber Cancer Institute, Boston, MA 02115, USA
Breast Cancer Res Treat 115:123-9. 2009..We sought to evaluate patient perceptions of how results had been shared from a large randomized cooperative group trial, and the impact of learning results... - Perceptions and management approaches of physicians who care for women with ductal carcinoma in situAnn Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Clin Breast Cancer 8:275-80. 2008..We sought in a longitudinal cohort study of women with DCIS to assess the attitudes and management approaches toward DCIS among physicians who provide care to women... - Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancerAnn H Partridge
Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
Fertil Steril 94:638-44. 2010..To compare markers of ovarian reserve between women exposed to cytotoxic chemotherapy for early stage breast cancer and matched controls... - Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104Ann H Partridge
Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
J Clin Oncol 28:2418-22. 2010..Patient adherence is critical in evaluating the effectiveness of an oral therapy. We sought to measure adherence among women randomly assigned to capecitabine in a preplanned substudy of a multicenter clinical trial... - Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VIAnn Partridge
Dana Farber Cancer Institute, Boston, MA 02115, USA
Eur J Cancer 43:1646-53. 2007..The likelihood of premature menopause has not been thoroughly explored in women who remain premenopausal after adjuvant chemotherapy for breast cancer... - Web-based survey of fertility issues in young women with breast cancerAnn H Partridge
Dana Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA
J Clin Oncol 22:4174-83. 2004..Young women with breast cancer often seek advice about whether treatment will affect their fertility. We sought to gain a better understanding of women's attitudes about fertility and how these concerns affect decision making... - Offering participants results of a clinical trial: sharing results of a negative studyAnn H Partridge
Department of Medical and Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Lancet 365:963-4. 2005..006). Most participants reported positive feelings about being offered results and about clinical trials in general. These preliminary findings from sharing clinical trial results are encouraging... - Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participantsAnn H Partridge
Dana Farber Cancer Institute, Boston, MA 02115, USA
J Natl Cancer Inst 96:629-32. 2004..Future studies should consider sharing trial results with patients and evaluating the process and its effect on both patients and clinicians... - Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancerAnn H Partridge
Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, D1210, Boston, MA 02215, USA
J Clin Oncol 21:602-6. 2003..We sought to estimate adherence and predictors of nonadherence in women starting tamoxifen as adjuvant breast cancer therapy... - Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907Alice B Kornblith
Dana Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 29:1022-8. 2011..The quality of life (QoL) substudy tested whether capecitabine treatment would be associated with a better QoL than standard chemotherapy... - Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situJennifer A Ligibel
Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
Ann Surg Oncol 16:106-12. 2009..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity... - Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancerJennifer A Ligibel
Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
J Womens Health (Larchmt) 19:1553-9. 2010..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients... - Medication errors involving oral chemotherapySaul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 116:2455-64. 2010..Given the expanding use of oral chemotherapies, the authors set out to examine errors in the prescribing, dispensing, administration, and monitoring of these drugs... - An approach to measuring the quality of breast cancer decisionsKaren Sepucha
Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Patient Educ Couns 65:261-9. 2007.... - The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancerMary E Abusief
Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Cancer 116:791-8. 2010..Little information is available regarding the effects of new adjuvant treatment regimens on menstrual functioning in premenopausal women with early breast cancer... - Long-term complications of adjuvant chemotherapy for early stage breast cancerAnn H Partridge
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Breast Dis 21:55-64. 2004..Interventions to ameliorate long-term complications are also addressed... - Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancerSara M Tolaney
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 24:5330-1. 2006 - Patient adherence and persistence with oral anticancer treatmentKathryn Ruddy
Department of Breast Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA
CA Cancer J Clin 59:56-66. 2009..Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described... - Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivorsJennifer A Ligibel
Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
J Clin Oncol 26:907-12. 2008..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors... - Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgeryKaren R Sepucha
General Medicine Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
BMC Med Inform Decis Mak 12:51. 2012..The purpose of this paper is to examine the acceptability, feasibility, reliability and validity of a new decision quality instrument that assesses the extent to which patients are informed and receive treatments that match their goals... - Coping and psychological distress in young adults with advanced cancerKelly M Trevino
Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, MA, USA
J Support Oncol 10:124-30. 2012..Little is known about how young adults (YAs) cope with cancer or about the relationship between coping and psychological distress in YAs with advanced cancer... - Doctor-patient communication about advance directives in metastatic breast cancerElissa M Ozanne
Institute for Technology Assessment, Massachusetts General Hospital, Boston, USA
J Palliat Med 12:547-53. 2009..This study examined whether or not patients with metastatic breast cancer had advance directives, and if so, with whom they discussed written plans for end-of-life decisions... - Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trialHadine Joffe
Perinatal and Reproductive Psychiatry Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
Menopause 17:908-16. 2010..Alternative strategies are needed. We hypothesized that augmentation of SSRI/SNRI therapy with hypnotic agents would optimize hot flash therapy by improving sleep and quality of life... - Pregnancy and breast cancer: epidemiology, treatment, and safety issuesAnn Partridge
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA
Oncology (Williston Park) 19:693-7; discussion 697-700. 2005.... - Treatment of breast cancer during pregnancyHarold J Burstein
Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
Expert Opin Pharmacother 3:423-8. 2002..Treatment decisions need to be tailored carefully to the individual, respecting both her clinical circumstances and her personal preferences... - Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controlsKathryn J Ruddy
Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Menopause 18:105-8. 2011..However, there has been little research to date comparing young survivors’ concerns and symptoms with those of young women of the same age and gravidity in the general population... - Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapyHarold J Burstein
Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 23:8340-7. 2005..The role of long-acting hematopoietic growth factors in facilitating every-2-week chemotherapy and minimizing hematologic toxicity has not been established... - Is there a role for decision aids in advanced breast cancer?Karen R Sepucha
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Med Decis Making 29:475-82. 2009..A diagnosis of metastatic breast cancer (BC) forces patients and providers to make difficult treatment decisions... - Breast cancer in young women: a new color or a different shade of pink?Jeffrey Peppercorn
J Clin Oncol 26:3303-5. 2008 - Fertility preservation: a vital survivorship issue for young women with breast cancerAnn H Partridge
J Clin Oncol 26:2612-3. 2008 - Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situSharon L Bober
Dana Farber Cancer Institute, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA Department of Biostatistics and Computational Biology, Dana Farber Cancer Center, Boston, MA, USA Harvard School of Public Health, Boston, MA, USA
J Sex Med 10:370-7. 2013..Bober SL, A Giobbie-Hurder, Emmons KM, Winer E, and Partridge A. Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med **;**:**-**... - Oral chemotherapy safety practices at US cancer centres: questionnaire surveySaul N Weingart
Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
BMJ 334:407. 2007..To characterise current safety practices for the use of oral chemotherapy... - Breast cancer risk communication: challenges and future research directions: workshop report (United States)Larissa Nekhlyudov
Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, MA 02215, USA
Cancer Causes Control 14:235-9. 2003..This report describes the proceedings of the conference... - Adherence to therapy with oral antineoplastic agentsAnn H Partridge
Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
J Natl Cancer Inst 94:652-61. 2002..Assessment of adherence among individuals with cancer and implementation of interventions in situations of poor adherence should improve clinical outcomes... - Fertility after breast cancer: questions aboundAnn H Partridge
J Clin Oncol 23:4259-61. 2005 - Young women's preferences about adjuvant endocrine therapy for breast cancerAnn H Partridge
Lancet Oncol 6:542-4. 2005 - Follow-up care of breast cancer survivorsAnn H Partridge
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Semin Oncol 30:817-25. 2003..Clinicians can also provide guidance and counseling as well as psychosocial support to patients regarding medical and psychosocial decisions that may be affected by their personal history of breast cancer... - Informing clinical trial participants about study resultsAnn H Partridge
Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
JAMA 288:363-5. 2002 - American Society of Clinical Oncology recommendations on fertility preservation in cancer patientsStephanie J Lee
Dana-Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 24:2917-31. 2006..CONCLUSION: Fertility preservation is often possible in people undergoing treatment for cancer. To preserve the full range of options, fertility preservation approaches should be considered as early as possible during treatment planning...